New technology tracks role of macrophages in cancer spread

Macrophages, cells that help engulf and destroy harmful organisms in the body, tend to be characterized as the Jekyll and Hydes of the immune system.

By studying macrophages, scientists are finding more effective immunotherapies to fight cancer. Photo: Morgridge Institute for Research

Macrophages are essential first responders in fighting off infections and marshaling other immune cells to the scene. But they also play a major role in contributing to the growth and metastasis of many cancers, especially breast and pancreatic cancer.

New studies at the Morgridge Institute for Research paint a far less simple picture of macrophages, however. Rather than just "good" and "bad" populations, they find a surprisingly wide range of functionality. Better defining those differences may lead to more effective immunotherapies to fight cancer.

Researchers Tiffany Heaster, Melissa Skala and colleagues describe using a combination of technologies to better reveal macrophage function and behavior.

The team applied fluorescence imaging to measure the precise metabolic activity of cells, then combined it with 3D microfluidic technology, allowing them to see in real time how the cells migrate and what role they play.

Importantly, the technologies helped them identify a distinct population of macrophage cells that migrate actively toward cancer cells in their model -- ones that may have outsized importance in promoting cancer growth.

The researchers used both mouse and human cells in the study and found comparable results, indicating this could be a powerful tool for examining the therapeutic potential of macrophages.

"There seems to be more of a spectrum of macrophage phenotypes, and it's been really hard to get at what these phenotypes look like with standard measures," says Heaster. "We need to understand these better before we can target the bad macrophages and promote the good ones."

Today, scientists classify two types of macrophages that operate in the tumor micro-environment. The first, called M1, kills cancer cells through methods such as piercing or eating cancer cells and stimulating secondary immune responses.

The second, M2, supports tumor growth by suppressing immune recognition and promoting blood vessel growth, a process called angiogenesis.

Addressing macrophages with immunotherapy would help because they are so diverse and may behave differently from one patient to the next, the researchers say. (National Science Foundation)

YOU MAY ALSO LIKE

Tiny golden bullets could help tackle asbestos-related cancers

Gold nanotubes could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos, according to a team of researchers at the Universities of Cambridge and Leeds.

Why it takes guts to protect the brain against infection

The brain is uniquely protected against invading bacteria and viruses, but its defence mechanism has long remained a mystery. Now, a study in mice, confirmed in human samples, has shown that the brain has a surprising ally in its protection: the gut.

Drug-resistant hospital bacteria persist even after deep cleaning, genomic study reveals

Scientists have used genome sequencing to reveal the extent to which a drug-resistant gastrointestinal bacterium can spread within a hospital, highlighting the challenge hospitals face in controlling infections.

Marmoset study finds single brain region linking depression and anxiety, heart disease, and people’s sensitivity to treatment

Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and anxiety disorders, but an antidepressant only successfully treats some of the symptoms.

Scientists discover key pathway in lysosomes that coronaviruses use to exit cells

Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body.

Postpartum depression may persist three years after giving birth

A National Institutes of Health study of 5,000 women has found that approximately 1 in 4 experienced high levels of depressive symptoms at some point in the three years after giving birth.